IMMUNOCORE HLDGS PLC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 2,678,650 | $79,475,545 | 0.07% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 3,771,474 | $118,348,857 | 0.09% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 11, 2025 |
| Sept. 30, 2025 | 3,754,560 | $136,403,165 | 0.10% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 3,961,880 | $137,516,856 | 0.10% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 11, 2026 |
| March 31, 2026 | 3,693,241 | $111,351,219 | 0.09% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 11, 2026 |
| June 30, 2026 | 3,638,241 | $115,514,154 | 0.07% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 14, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.